This is a preprint.
Comprehensive characterization of tumor therapeutic response with simultaneous mapping cell size, density, and transcytolemmal water exchange
- PMID: 39130198
- PMCID: PMC11312621
Comprehensive characterization of tumor therapeutic response with simultaneous mapping cell size, density, and transcytolemmal water exchange
Update in
-
Comprehensive characterization of tumor therapeutic response via simultaneous mapping of cell size, density, and transcytolemmal water exchange.Magn Reson Imaging. 2025 Oct;122:110433. doi: 10.1016/j.mri.2025.110433. Epub 2025 Jun 1. Magn Reson Imaging. 2025. PMID: 40460946
Abstract
Early assessment of tumor therapeutic response is an important topic in precision medicine to optimize personalized treatment regimens and reduce unnecessary toxicity, cost, and delay. Although diffusion MRI (dMRI) has shown potential to address this need, its predictive accuracy is limited, likely due to its unspecific sensitivity to overall pathological changes. In this work, we propose a new quantitative dMRI-based method dubbed EXCHANGE (MRI of water Exchange, Confined and Hindered diffusion under Arbitrary Gradient waveform Encodings) for simultaneous mapping of cell size, cell density, and transcytolemmal water exchange. Such rich microstructural information comprehensively evaluates tumor pathologies at the cellular level. Validations using numerical simulations and in vitro cell experiments confirmed that the EXCHANGE method can accurately estimate mean cell size, density, and water exchange rate constants. The results from in vivo animal experiments show the potential of EXCHANGE for monitoring tumor treatment response. Finally, the EXCHANGE method was implemented in breast cancer patients with neoadjuvant chemotherapy, demonstrating its feasibility in assessing tumor therapeutic response in clinics. In summary, a new, quantitative dMRI-based EXCHANGE method was proposed to comprehensively characterize tumor microstructural properties at the cellular level, suggesting a unique means to monitor tumor treatment response in clinical practice.
Keywords: arbitrary gradient waveform; diffusion MRI; microstructural imaging; time-dependent diffusion; tumor response; water exchange.
Figures






Similar articles
-
Comprehensive characterization of tumor therapeutic response via simultaneous mapping of cell size, density, and transcytolemmal water exchange.Magn Reson Imaging. 2025 Oct;122:110433. doi: 10.1016/j.mri.2025.110433. Epub 2025 Jun 1. Magn Reson Imaging. 2025. PMID: 40460946
-
Improving MR cell size imaging by inclusion of transcytolemmal water exchange.NMR Biomed. 2022 Dec;35(12):e4799. doi: 10.1002/nbm.4799. Epub 2022 Jul 28. NMR Biomed. 2022. PMID: 35794795 Free PMC article.
-
Impact of transcytolemmal water exchange on estimates of tissue microstructural properties derived from diffusion MRI.Magn Reson Med. 2017 Jun;77(6):2239-2249. doi: 10.1002/mrm.26309. Epub 2016 Jun 25. Magn Reson Med. 2017. PMID: 27342260 Free PMC article.
-
MR cell size imaging with temporal diffusion spectroscopy.Magn Reson Imaging. 2021 Apr;77:109-123. doi: 10.1016/j.mri.2020.12.010. Epub 2020 Dec 16. Magn Reson Imaging. 2021. PMID: 33338562 Free PMC article. Review.
-
Ytterbium chelated to 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid,10-orthoaminoanilide.2011 Nov 26 [updated 2012 Jan 5]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2011 Nov 26 [updated 2012 Jan 5]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 22238803 Free Books & Documents. Review.
References
-
- Mieog JSD, van de Hage Ja, van de Velde CJH. Neoadjuvant chemotherapy for operable breast cancer. The British journal of surgery 2007;94:1189–1200. - PubMed
-
- Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. Journal of the National Cancer Institute 2000;92:205–216. - PubMed
-
- Hylton NM, Blume JD, Bernreuter WK, Pisano ED, Rosen MA, Morris EA, Weatherall PT, Lehman CD, Newstead GM, Polin S, Marques HS, Esserman LJ, Schnall MD. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology 2012;263(3):663–672. - PMC - PubMed
-
- Li W, Newitt DC, Gibbs J, Wilmes LJ, Jones EF, Arasu VA, Strand F, Onishi N, Nguyen AA, Kornak J, Joe BN, Price ER, Ojeda-Fournier H, Eghtedari M, Zamora KW, Woodard SA, Umphrey H, Bernreuter W, Nelson M, Church AL, Bolan P, Kuritza T, Ward K, Morley K, Wolverton D, Fountain K, Lopez-Paniagua D, Hardesty L, Brandt K, McDonald ES, Rosen M, Kontos D, Abe H, Sheth D, Crane EP, Dillis C, Sheth P, Hovanessian-Larsen L, Bang DH, Porter B, Oh KY, Jafarian N, Tudorica A, Niell BL, Drukteinis J, Newell MS, Cohen MA, Giurescu M, Berman E, Lehman C, Partridge SC, Fitzpatrick KA, Borders MH, Yang WT, Dogan B, Goudreau S, Chenevert T, Yau C, DeMichele A, Berry D, Esserman LJ, Hylton NM. Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL. NPJ Breast Cancer 2020;6(1):63. - PMC - PubMed
-
- Partridge SC, Zhang Z, Newitt DC, Gibbs JE, Chenevert TL, Rosen MA, Bolan PJ, Marques HS, Romanoff J, Cimino L, Joe BN, Umphrey HR, Ojeda-Fournier H, Dogan B, Oh K, Abe H, Drukteinis JS, Esserman LJ, Hylton NM. Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial. Radiology 2018;289(3):618–627. - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources